142 related articles for article (PubMed ID: 37815579)
1. A qualitative exploration of fear of progression in patients with nasopharyngeal carcinoma treated with proton and heavy ion therapy.
Zheng M; Wang S; Zhu Y; Wan H
Support Care Cancer; 2023 Oct; 31(12):622. PubMed ID: 37815579
[TBL] [Abstract][Full Text] [Related]
2. Trajectories of fear of progression in nasopharyngeal carcinoma patients receiving proton and heavy ion therapy.
Zheng M; Wang S; Zhu Y; Wan H
Support Care Cancer; 2023 Oct; 31(12):630. PubMed ID: 37843679
[TBL] [Abstract][Full Text] [Related]
3. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
6. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
Hwang JM; Fu KK; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
[TBL] [Abstract][Full Text] [Related]
7. Triggers and Coping Strategies for Fear of Cancer Recurrence in Cancer Survivors: A Qualitative Study.
Zhang X; Sun D; Wang Z; Qin N
Curr Oncol; 2022 Dec; 29(12):9501-9510. PubMed ID: 36547160
[TBL] [Abstract][Full Text] [Related]
8. A qualitative analysis of patient's lived experience on their treatment journey with nasopharyngeal carcinoma.
Ng JPZ; Lam WYH; Pow EHN; Botelho MG
J Dent; 2023 Jul; 134():104518. PubMed ID: 37088259
[TBL] [Abstract][Full Text] [Related]
9. The Lived Experiences of Adolescents With Cancer: A Phenomenological Study.
Chien CH; Chang YY; Huang XY
Clin Nurs Res; 2020 May; 29(4):217-225. PubMed ID: 30188183
[TBL] [Abstract][Full Text] [Related]
10. An exploration of life attitudes in patients with nasopharyngeal carcinoma.
Chou HL; Liaw JJ; Yu LH; Tang WR
Cancer Nurs; 2007; 30(4):317-23. PubMed ID: 17666983
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal granulomatous mass after radiotherapy for nasopharyngeal carcinoma.
Yang L; Li H; Wang H; Zhang H; Wang S; Fry AN; Han WW; Wang D
Auris Nasus Larynx; 2016 Jun; 43(3):330-5. PubMed ID: 26791589
[TBL] [Abstract][Full Text] [Related]
12. Individual and Dyadic Coping and Fear of Progression in Mothers and Fathers of Children with Hematologic Cancer.
Clever K; Schepper F; Maier S; Christiansen H; Martini J
Fam Process; 2020 Sep; 59(3):1225-1242. PubMed ID: 31408204
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.
Qiu WZ; Peng XS; Xia HQ; Huang PY; Guo X; Cao KJ
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1563-1572. PubMed ID: 28342002
[TBL] [Abstract][Full Text] [Related]
14. Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates.
Goebel S; Mehdorn HM
Support Care Cancer; 2019 Sep; 27(9):3521-3529. PubMed ID: 30684045
[TBL] [Abstract][Full Text] [Related]
15. Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results.
Jiří K; Vladimír V; Michal A; Matěj N; Silvia S; Pavel V; Kateřina D; Jana P; Barbora O; Eliška R; Petr L; Matěj P; Alexander G; Jozef R
Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):763-769. PubMed ID: 32623508
[TBL] [Abstract][Full Text] [Related]
16. The role of Indonesian patients' health behaviors in delaying the diagnosis of nasopharyngeal carcinoma.
Fles R; Bos ACRK; Supriyati ; Rachmawati D; Waliyanti E; Tan IB; Haryana SM; Schmidt MK; Dewi FST
BMC Public Health; 2017 May; 17(1):510. PubMed ID: 28545416
[TBL] [Abstract][Full Text] [Related]
17. When health care workers became patients with COVID-19: A qualitative study.
Du L; Liu Q; Chen Q; Wang XQ; Fang S; Chen P; Chen J; Zhang ZJ; Liu Z; Yang BX; Guo Q; Luo D
Int J Nurs Pract; 2022 Feb; 28(1):e13034. PubMed ID: 34935249
[TBL] [Abstract][Full Text] [Related]
18. Significance of boost dose for T4 nasopharyngeal carcinoma with residual primary lesion after intensity-modulated radiotherapy.
Fei Z; Xu T; Qiu X; Li M; Chen T; Li L; Huang C; Chen C
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2047-2055. PubMed ID: 33392660
[TBL] [Abstract][Full Text] [Related]
19. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma.
Uezono H; Indelicato DJ; Rotondo RL; Sandler ES; Katzenstein HM; Dagan R; Mendenhall WM; Mailhot Vega R; Brennan BM; Bradley JA
Pediatr Blood Cancer; 2019 Dec; 66(12):e27990. PubMed ID: 31524334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
